• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/23

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

23 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)
Imipramine
Tricyclic
SidEf- sedation, anticholinergic effect (dry mouth, constipation, blurred vision, urinary retention etc.)
OvDose- dysrhytmias (when combined with CNS depressor)
t1\2- 4-18 h
Desipramine
Tricyclic
NA selective.
SidEf- sedation, anticholinergic effect.
OvrDos- dysrhytmia (when combined with CNS depressor)
t1\2- 12-24h
Amitriptyline
Tricyclic
SidEf- sedation, anticholinergic effect.
OveDos- dysrhytmias (when combine with CNS depressor).
t1\2- 12-24h.
widely used, also for neuropathic pain.
Nortriptyline
Tricyclic
NA selective (slight)
SidEf- sedation, anticholinergic effect.
OvrDos- dysrhytmia (when combined with CNS depressor)
t1\2- 24-96h.
less sedative.
Clomipramine
Tricyclic
Sidef- sedation, anticholinergic effect.
OvrDos- dysryhtmia (when combine with CNS depressor).
t1\2- 18-24h.
also used for anxiety disorders
Tricyclic
a group of antidepressant that inhibit Noradrenalin (NA) \ serotonin (5HT) reuptake .type of drugs-
Imipramine
Desipramine
Amitriptyline
Nortriptyline
Clomipramine
type of drugs-
Imipramine
Desipramine
Amitriptyline
Nortriptyline
Clomipramine
Fluoxetine
AKA Prozac
SSRI
SidEf- nausea, diarrhea, agitation, insomnia, anorgasmia, inhibit metabolism of other drugs.
OvrDos- low risk, most not be used combined with MAOI.
t1\2- 24-96h
Fluvoxamine
SSRI
SidEf- nausea, diarrhea, agitation, insomnia, anorgasmia, inhibit metabolism of other drugs.
OvrDos- low risk, most not be used combined with MAOI.
t1\2- 18-24h
Paroxetine
SSRI
SidEf- nausea, diarrhea, agitation, insomnia, anorgasmia, inhibit metabolism of other drugs.
OvrDos- low risk, most not be used combined with MAOI.
t1\2- 18-24.
less nausea then other SSRI.
Citalopram
SSRI
SidEf- nausea, diarrhea, agitation, insomnia, anorgasmia, inhibit metabolism of other drugs.
OvrDos- low risk, most not be used combined with MAOI.
t1\2- 24-36.
Withdrawal reaction.
Sertraline
SSRI
SidEf- nausea, diarrhea, agitation, insomnia, anorgasmia, inhibit metabolism of other drugs.
OvrDos- low risk, most not be used combined with MAOI.
t1\2- 24-36h
SSRI
Selective serotonin (5HT) reuptake inhibitors class of antidepressant drugs, include:
Fluoxetine
Fluvoxamine
Paroxetine
Citalopram
Sertraline
Phenelzine
MAOI
SidEf- nausea, diarrhea, agitation, insomnia, anorgasmia, inhibit metabolism of other drugs.
OvrDos- low risk, most not be used combined with MAOI.
t1\2- 24-36.
Withdrawal reaction.
Tranylcypromine
MAOI
SidEf- Cheese reaction to tyramine (foods), anticholinergic effect, HypoTens, insomnia, weight gain, liver damage (rare).
OvrDos- interaction with Tricyclic, opioids, sympathomimetics), risk of sever HT due to cheese reaction.
t1\2- 1-2 h (irreversible binding)
Isocarboxazid
MAOI
SidEf- Chees reaction to tyramine (foods), anticholinergic effect, HypoTens, insomnia, weight gain, liver damage (rare).
OvrDos- interaction with Tricyclic, opioids, sympathomimetics), risk of sever HT due to cheese reaction.
t1\2- 39h
Moclobemide
MAOI
MAO-A selective.
SidEf- nausea, insomnia, agitation.
OvrDos- less sever interaction the other MAOI, no cheese reaction (tyramine).
t1\2- 1-2h.
safer then other MAOIs.
MAOIs
Monoamine oxidase (A or B) inhibitors, inhibit formation of monoamines (neurotransmitters).
types:
Phenelzine
Tranylcypromine
Isocarboxazid
Moclobemide
Maprotiline
selective NA uptake inhibitor
SidEf- sedation, anticholinergic effect.
OvrDos- dysrhytmias (when combined with CNS depressor).
t1\2- 40h
no significant advantages over tricyclic.
Reboxetine
selective NA uptake inhibitor
SidEf- dizziness, insomnia, anticholinergic effect.
OvrDos- safe, low risk of dysrhytmia.
t1\2- 12h
safer & fewer SidEf then tricyclic.
Venlafaxine
weak non selective NA\5HT uptake inhibitor. also blocks receptors.
SidEf- nausea, diarrhea, agitation, insomnia, anorgasmia, inhibit metabolism of other drugs.
OvrDos- safe.
withdrawal effects common.
t1\2- 5h
faster working, better with resistant patients.
Bupropion
weak Dopamine uptake inhibitor
SidEf- dizziness, anxiety, seizures.
OvrDos- safe.
t1\2- 12h
used mainly in depression associated with anxiety.
Trazodone
weak serotonin (5HT) uptake inhibitor, also blocks receptors.
SidEf- sedation, HypoTens, dysrhytmia.
OvrDos- safe.
t1\2- 6-12h
similar- Nafazodone, Mianserin
Mirtazapine
block alfa2, 5HT2/3 receptors
SidEf- dry mouth, sedation, weight gain.
OvrDos- no serous interaction.
t1\2- 20-40h.
faster onset then other.